Literature DB >> 36239748

Determinants of ureteral obstruction after percutaneous nephrolithotomy.

Harry H Lee1,2, Heiko Yang3, Patrick Martin-Tuite4, Rei Unno1, Fadl Hamouche1, Justin Ahn1, David Bayne1, Marshall Stoller1, Thomas Chi1.   

Abstract

BACKGROUND: Ureteral obstruction after percutaneous nephrolithotomy (PCNL) may require prolonged drainage with a nephrostomy tube (NT) or ureteral stent, but it is not well understood how and why this occurs. The goal of this study was to identify risk factors associated with postoperative ureteral obstruction to help guide drainage tube selection.
METHODS: Prospective data from adult patients enrolled in the Registry for Stones of the Kidney and Ureter (ReSKU) who underwent PCNL from 2016 to 2020 were used. Patients who had postoperative NTs with antegrade imaging-based flow assessment on postoperative day one (POD1) were included. Patients with transplanted kidneys or those without appropriate preoperative imaging were excluded. We assessed the association between patient demographics, stone characteristics, and intraoperative factors using POD1 antegrade flow, a proxy for ureteral patency, as the primary outcome. Stepwise selection was used to develop a multivariate logistic regression model controlling for BMI, stone location, stone burden, ipsilateral ureteroscopy (URS), access location, estimated blood loss, and operative time.
RESULTS: We analyzed 241 cases for this study; 204 (84.6%) had a visual clearance of stone. Antegrade flow on POD1 was absent in 76 cases (31.5%). A multivariate logistic regression model found that stones located anywhere other than in the renal pelvis (OR 2.63, 95% CI 1.29-5.53; p = 0.01), non-lower pole access (OR 2.81, 95% CI 1.42-5.74; p < 0.01), and concurrent ipsilateral URS (OR 2.17, 95% CI 1.02-4.65; p = 0.05) increased the likelihood of obstruction. BMI, pre-operative stone burden, EBL, and operative time did not affect antegrade flow outcomes.
CONCLUSION: Concurrent ipsilateral URS, absence of stones in the renal pelvis, and non-lower pole access are associated with increased likelihood of ureteral obstruction after PCNL. Access location appears to be the strongest predictor. Recognizing these risk factors can be helpful in guiding postoperative tube management.
© 2022. The Author(s).

Entities:  

Keywords:  Kidney stones; Percutaneous nephrolithotomy; Totally tubeless; Ureteral obstruction

Mesh:

Year:  2022        PMID: 36239748      PMCID: PMC9584844          DOI: 10.1007/s00240-022-01365-8

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   2.861


  12 in total

Review 1.  Tubeless percutaneous nephrolithotomy--the new standard of care?

Authors:  D E Zilberman; M E Lipkin; J J de la Rosette; M N Ferrandino; C Mamoulakis; M P Laguna; G M Preminger
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

Review 2.  Tubeless percutaneous nephrolithotomy: evaluation of minimal invasive exit strategies after percutaneous stone treatment.

Authors:  Julian Veser; Harun Fajkovic; Christian Seitz
Journal:  Curr Opin Urol       Date:  2020-09       Impact factor: 2.309

3.  Infundibular stenosis after percutaneous nephrolithotomy.

Authors:  J Kellogg Parsons; Thomas W Jarrett; Vanessa Lancini; Louis R Kavoussi
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

4.  Contrast Enhanced Ultrasound as a Radiation-Free Alternative to Fluoroscopic Nephrostogram for Evaluating Ureteral Patency.

Authors:  Thomas Chi; Manint Usawachintachit; Stefanie Weinstein; Maureen P Kohi; Andrew Taylor; David T Tzou; Helena C Chang; Marshall Stoller; John Mongan
Journal:  J Urol       Date:  2017-07-23       Impact factor: 7.450

5.  Feasibility of Antegrade Contrast-enhanced US Nephrostograms to Evaluate Ureteral Patency.

Authors:  Thomas Chi; Manint Usawachintachit; John Mongan; Maureen P Kohi; Andrew Taylor; Priyanka Jha; Helena C Chang; Marshall Stoller; Ruth Goldstein; Stefanie Weinstein
Journal:  Radiology       Date:  2016-10-19       Impact factor: 11.105

6.  Methylene Blue Injection as an Alternative to Antegrade Nephrostography to Assess Urinary Obstruction After Percutaneous Nephrolithotomy.

Authors:  Matthew D Truesdale; Molly Elmer-Dewitt; Marco Sandri; Bogdana Schmidt; Ian Metzler; Adam Gadzinski; Marshall L Stoller; Thomas Chi
Journal:  J Endourol       Date:  2016-04       Impact factor: 2.942

7.  Totally tubeless percutaneous nephrolithotomy.

Authors:  Tim J Crook; C R Lockyer; Stephen R Keoghane; Byron H Walmsley
Journal:  J Endourol       Date:  2008-02       Impact factor: 2.942

8.  Comparison of totally tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a randomized, clinical trial.

Authors:  N Moosanejad; A Firouzian; S A Hashemi; M Bahari; M Fazli
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

9.  Are we fearful of tubeless percutaneous nephrolithotomy? Assessing the need for tube drainage following percutaneous nephrolithotomy.

Authors:  Joel E Abbott; Samuel G Deem; Natalie Mosley; Gary Tan; Nathan Kumar; Julio G Davalos
Journal:  Urol Ann       Date:  2016 Jan-Mar

Review 10.  Complications associated with percutaneous nephrolithotomy.

Authors:  Eric Taylor; Joe Miller; Thomas Chi; Marshall L Stoller
Journal:  Transl Androl Urol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.